Story perspectives
China's Biotech Stocks Surge 60% Amid New Deals
6/16/2025
35 4
1 of 1
Story summary
- China's biotechnology stocks are experiencing a significant rebound after four years of decline.
- The Hang Seng Biotech Index has surged over 60% since January.
- Investor interest has grown following two billion-dollar licensing deals with foreign companies.
- Upcoming listings of local producers are boosting the sector's appeal.
